SCHEMBL160600

SCHEMBL160600

[CH2]c1c(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)c2ccc3cccc4ccc1c2c43

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ CYP2A6 P11509 1/20 0.36
▸ ABCG2 Q9UNQ0 4/20 0.36
▸ ABCC1 P33527 2/20 0.36
▸ ABCB1 P08183 2/20 0.36
▸ CYP1A1 P04798 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6579959 0.84 ABCG2 (0.41) ENPP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL15777410 0.82 ENPP1 (0.36) ENPP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL28262323 0.79 APP (0.44) ENPP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL13145980 0.79 CA1 (0.44) ENPP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL25277498 0.77 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ACYP1A2GAA
SCHEMBL28078075 0.77 ALOX5 (0.43) ENPP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL29227267 0.76 CYP1A2 (0.37) ENPP1ALDH1A1MEN1KMT2ACYP1A2
Methoxymethane SCHEMBL27988234 0.75 ALOX5 (0.42) ENPP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL30307098 0.75 NTRK1 (0.47) ALDH1A1MEN1KMT2ACYP1A2GAA
SCHEMBL28935252 0.74 ABCG2 (0.41) ENPP1ALDH1A1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427743-A4 PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES EPOCH BIOSCIENCES INC (US) 2007-04-04 — — EP claimed
EP-1427743-A2 PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES Epoch Biosciences, Inc. (US) 2004-06-16 — — EP claimed
WO-2003022859-A2 PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES EPOCH BIOSCIENCES, INC. (US) 2003-03-20 — — WO claimed
EP-0749436-A1 COMPOSITIONS AND METHODS FOR USE IN THE SYNTHESIS OF OLIGONUCLEOTIDES BECKMAN INSTRUMENTS, INC. (US) 1996-12-27 — — EP claimed
WO-1995024413-A1 COMPOSITIONS AND METHODS FOR USE IN THE SYNTHESIS OF OLIGONUCLEOTIDES BECKMAN INSTRUMENTS, INC. (US) 1995-09-14 — — WO claimed
WO-2023096715-A9 IMMUNOMODULATORY GLYCOSPHINGOLIPIDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-07-20 — — WO disclosed
WO-2023096715-A2 IMMUNOMODULATORY GLYCOSPHINGOLIPIDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-06-01 — — WO disclosed
EP-3661898-A1 PROCESS FOR DEOXYFLUORINATION OF PHENOLS Studiengesellschaft Kohle MbH (DE) 2020-06-10 — — EP disclosed
EP-3618836-A1 TRITERPENE SAPONIN ANALOGUES Adjuvance Technologies, Inc. (US) 2020-03-11 — — EP disclosed
EP-3609505-A1 TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS Adjuvance Technologies, Inc. (US) 2020-02-19 — — EP disclosed
WO-2019025137-A1 PROCESS FOR DEOXYFLUORINATION OF PHENOLS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2019-02-07 — — WO disclosed
WO-2018200645-A1 TRITERPENE SAPONIN ANALOGUES ADJUVANCE TECHNOLOGIES, INC. (US) 2018-11-01 — — WO disclosed
WO-2004096286-A2 ANTIVIRAL PHOSPHONATE ANALOGS GILEAD SCIENCES, INC. (US) 2004-11-11 — — WO disclosed
WO-2004041889-A2 POLYCYCLIC SUGAR SURROGATE-CONTAINING OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATION ISIS PHARMACEUTICALS, INC. (US) 2004-05-21 — — WO disclosed
EP-1373286-A2 LINKERS AND CO-COUPLING AGENTS FOR OPTIMIZATION OF OLIGONUCLEOTIDE SYNTHESIS AND PURIFICATION ON SOLID SUPPORT THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2004-01-02 — — EP disclosed
WO-2002072791-A2 LINKERS AND CO-COUPLING AGENTS FOR OPTIMIZATION OF OLIGONUCLEOTIDE SYNTHESIS AND PURIFICATION ON SOLID SUPPORT THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2002-09-19 — — WO disclosed
EP-1163256-A1 HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE Hollis-Eden Pharmaceuticals Inc. (US) 2001-12-19 — — EP disclosed
EP-1144372-A1 SULPHOHYDROXAMIC ACIDS AND SULPHOHYDROXAMATES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2001-10-17 — — EP disclosed
WO-2000056757-A1 IMMUNOMODULATORY STEROIDS, IN PARTICULAR THE HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2000-09-28 — — WO disclosed
WO-2000042002-A1 SULPHOHYDROXAMIC ACIDS AND SULPHOHYDROXAMATES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-20 — — WO disclosed
Send feedback